-
-
-
-
-
-
-
Galmed and Tissue Dynamics identify cardiac fibrosis pathway
-
-
-
-
-
-
-
Galmed CEO outlines drug development plans in shareholder letter
-
-
-
-
-
-
-
Galmed Pharma (GLMD) reports Results from Aramchol Phase 3 Open Label part
-
-
456,615 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

